EmphyCorp's Patented Non-Steroidal Nasal Spray has been used by over 2 Million Patients Globally in over 200 Hospitals over the past 5 years that includes 300,000 COPD patients, "Unmet Needs ...

EmphyCorp's goal is to get N115 to market as quickly as possible to help provide immediate improvement in "Quality of Life" for millions of Patients suffering from chronic breathing diseases.